Bempedoic Acid Pregnancy Surveillance Program

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorEsperion Therapeutics, Inc.

About this trial

Bempedoic acid pregnancy surveillance program

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Primary care

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Bempedoic Acid

    Drug

    Bempedoic Acid 180 MG

  • Bempedoic Acid / Ezetimibe

    Drug

    Bempedoic Acid 180 MG / Ezetimibe 10 MG

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Major congenital malformations (MCM)

An abnormality of body structure or function that is present at birth, is of prenatal origin (i.e., birth defect), has significant medical, social, or cosmetic consequences for the affected individual, and typically requires medical intervention (CDC 2019a). MCMs will be defined and coded with criteria specified by US CDC Metropolitan Atlanta Congenital Defects Program (MACDP).

Time frame
Birth up to 12 months

Secondary outcomes

1

Minor congenital malformation

An anomaly or abnormality of body structure that is present at birth, is of prenatal origin (i.e., birth defect), poses no significant health problem in the neonatal period, and tends to have limited social or cosmetic consequences for the affected individual (CDC 2019a). The surveillance program defines and codes minor congenital malformations with criteria specified as defined by CDC (CDC 2017).

Time frame
Birth up to 12 months
2

Spontaneous abortion

An involuntary fetal loss or the expulsion of the products of conception occurring at \< 20 gestational weeks.

Time frame
Time of conception up to birth
3

Stillbirth

As defined by the American College of Obstetricians and Gynecologists (ACOG), an involuntary fetal loss occurring at ≥ 20 gestational weeks or, if gestational age is unknown, a fetus weighing ≥ 350 g.

Time frame
Time of conception up to birth
4

Elective termination

A voluntary fetal loss or interruption of pregnancy, including pregnancy termination that occurs electively, to preserve maternal health or due to fetal abnormalities.

Time frame
Time of conception up to birth

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.